Acacia Research (NASDAQ: ACTG) director lines up sale of RSU shares

Rhea-AI Filing Summary

Acacia Research Corporation (ACTG) director Maureen E. O'Connell filed a Rule 144 notice to sell up to 10,000 shares of ACTG common stock through UBS Financial Services Inc. The shares relate to RSU vesting on 05/26/2024, with the proposed sale by 08/19/2026 on NASDAQ.

Key Figures

Shares to be sold: 10,000 shares Proposed sale date: 08/19/2026 RSU vesting date: 05/26/2024 +2 more

5 metrics

Shares to be sold 10,000 shares Common Stock proposed to be sold under Rule 144

Proposed sale date 08/19/2026 Approximate date of sale for the Rule 144 transaction

RSU vesting date 05/26/2024 Date tied to RSU vesting for the shares to be sold

Shares outstanding 97,586,805 shares Number of shares outstanding shown in the securities information section

Aggregate market value 45,000 Aggregate market value figure listed with the 10,000 shares

Key Terms

Rule 144, RSU Vesting, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

RSU Vesting financial

"Common Stock | 05/26/2024 | RSU Vesting | Acacia Research Corporation"

RSU vesting is the process by which restricted stock units — a promise by a company to give shares to an employee — become actual, owned shares over time or when certain goals are met. Investors care because vested shares can dilute existing ownership when issued, and the timing of vesting affects when employees can sell shares, which can influence share supply, insider selling patterns, and company incentives.

attorney-in-fact regulatory

"for UBS Financial Services Inc, as attorney-in-fact for Maureen E. O'Connell"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What did Acacia Research (ACTG) disclose in this Form 144 filing?

Acacia Research (ACTG) disclosed that director Maureen E. O'Connell filed a Rule 144 notice to sell up to 10,000 shares of ACTG common stock through UBS Financial Services Inc, with a proposed sale by 08/19/2026 on NASDAQ.

How many Acacia Research (ACTG) shares are covered by Maureen E. O’Connell’s Rule 144 notice?

The Rule 144 notice covers up to 10,000 shares of Acacia Research (ACTG) common stock. These shares are associated with RSU vesting on 05/26/2024 and may be sold through UBS Financial Services Inc by 08/19/2026.

Who is selling Acacia Research (ACTG) shares under this Rule 144 and through which broker?

The planned sale involves Maureen E. O’Connell, a director of Acacia Research (ACTG), as the beneficial owner. The shares are to be sold through UBS Financial Services Inc, which is identified as the broker handling the transaction.

What is the relationship of the shares to RSU vesting for Acacia Research (ACTG)?

The 10,000 shares referenced in the filing are tied to RSU vesting on 05/26/2024 at Acacia Research (ACTG). The Rule 144 notice indicates that these vested RSU-related shares may be sold on or before 08/19/2026 subject to Rule 144 conditions.

When is the proposed sale date for the Acacia Research (ACTG) shares under this Form 144?

The notice lists a proposed sale date of 08/19/2026 for the Acacia Research (ACTG) common shares. This date reflects when the securities may be sold under Rule 144, assuming all rule requirements and conditions are satisfied at that time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 12:36 PM Accepted by SEC EDGAR 08/19/2026 - 12:35 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001111318
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Acacia Research Corporation
SEC File Number	001-37721
Address of Issuer	777 Third Avenue 26th Floor New York NEW YORK 10017
Phone	332-236-8500
Name of Person for Whose Account the Securities are To Be Sold	Maureen E. O'Connell
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	10000	45000	97586805	08/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	05/26/2024	RSU Vesting	Acacia Research Corporation			10000	08/19/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/19/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Maureen E. O'Connell
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)